Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

NULL
   
  • Closing Price Chg:
    -1.00p
  • 52 Week High: NULL
  • 52 Week Low: 18.00p
  • Currency: UK Pounds
  • Shares Issued: 615.38m
  • Volume: 0
  • Beta: 0.12

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Mar-25 Interim 40.63 (12.62) (1.77)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-20 105.57 (22.57) (3.80)p n/a n/a n/a n/a 0.0%
30-Sep-21 125.06 (9.18) (1.93)p n/a n/a n/a n/a 0.0%
30-Sep-22 157.71 (21.38) (4.34)p n/a n/a n/a n/a 0.0%
30-Sep-23 103.96 (24.70) (3.21)p n/a n/a n/a n/a 0.0%
30-Sep-24 90.36 (45.92) (5.99)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-25 79.70 (4.10) 26.63p 0.8 n/a n/a n/a 0.0%
30-Sep-26 83.70 11.30 1.10p 19.4 n/a -96% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

BMK Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change -1.00p
% Change 0.00 %
52 Week High NULL
52 Week Low 18.00p
Volume 0
Shares Issued 615.38m
Beta 0.12

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.95% above the market average72.95% above the market average72.95% above the market average72.95% above the market average72.95% above the market average
95.35% above the sector average95.35% above the sector average95.35% above the sector average95.35% above the sector average95.35% above the sector average
Price Trend
74.44% below the market average74.44% below the market average74.44% below the market average74.44% below the market average74.44% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Income Not Available
Growth
57.32% below the market average57.32% below the market average57.32% below the market average57.32% below the market average57.32% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average

BMK Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

BMK Key Personnel

CEO Trond Williksen
Chair Tripp Lane

Top of Page